Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Chronic Pain in Sickle Cell Disease
NCT05519111Phase 2Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in sickle cell disease (SCD), sponsored by Icahn School of Medicine at Mount Sinai. Started Apr 2025; status: recruiting.
02
Drugs
dronabinol
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT05519111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05519111.